NORTHERN TRUST CORP - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314507. A total of 31 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q3 2020$32,000
-45.8%
192,7240.0%0.00%
Q2 2020$59,000
+195.0%
192,724
+119.3%
0.00%
Q1 2020$20,000
+566.7%
87,889
+485.0%
0.00%
Q4 2019$3,000
-25.0%
15,0230.0%0.00%
Q3 2019$4,000
-78.9%
15,0230.0%0.00%
Q2 2019$19,000
-29.6%
15,0230.0%0.00%
Q1 2019$27,00015,0230.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q2 2020
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 90,838$162,0000.11%
Winning Points Advisors, LLC 13,549$24,0000.02%
A.R.T. Advisors, LLC 26,312$47,0000.00%
Blume Capital Management, Inc. 425$1,0000.00%
VANGUARD GROUP INC 473,164$842,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 35$00.00%
UBS Group AG 7,791$14,0000.00%
MARINO, STRAM & ASSOCIATES LLC 61$00.00%
Advisor Group, Inc. 350$1,0000.00%
HUNTINGTON NATIONAL BANK 87$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders